首页> 美国卫生研究院文献>International Journal of Health Policy and Management >Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions
【2h】

Measuring the Benefits of Healthcare: DALYs and QALYs – Does the Choice of Measure Matter? A Case Study of Two Preventive Interventions

机译:衡量医疗保健的益处:DALY和QALY –衡量选择是否重要?两种预防性干预的案例研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: The measurement of health benefits is a key issue in health economic evaluations. There is very scarce empirical literature exploring the differences of using quality-adjusted life years (QALYs) or disability-adjusted life years (DALYs) as benefit metrics and their potential impact in decision-making. >Methods: Two previously published models delivering outputs in QALYs, were adapted to estimate DALYs: a Markov model for human papilloma virus (HPV) vaccination, and a pneumococcal vaccination deterministic model (PNEUMO). Argentina, Chile, and the United Kingdom studies were used, where local EQ-5D social value weights were available to provide local QALY weights. A primary study with descriptive vignettes was done (n = 73) to obtain EQ-5D data for all health states included in both models. Several scenario analyses were carried-out to evaluate the relative importance of using different metrics (DALYS or QALYs) to estimate health benefits on these economic evaluations. >Results: QALY gains were larger than DALYs avoided in all countries for HPV, leading to more favorable decisions using the former. With discounting and age-weighting – scenario with greatest differences in all countries – incremental DALYs avoided represented the 75%, 68%, and 43% of the QALYs gained in Argentina, Chile, and United Kingdom respectively. Differences using QALYs or DALYs were less consistent and sometimes in the opposite direction for PNEUMO. These differences, similar to other widely used assumptions, could directly influence decision-making using usual gross domestic products (GDPs) per capita per DALY or QALY thresholds. >Conclusion: We did not find evidence that contradicts current practice of many researchers and decision-makers of using QALYs or DALYs interchangeably. Differences attributed to the choice of metric could influence final decisions, but similarly to other frequently used assumptions.
机译:>背景:健康收益的衡量是健康经济评估中的关键问题。很少有经验文献探索使用质量调整生命年(QALYs)或残疾调整生命年(DALYs)作为收益指标的差异及其在决策中的潜在影响。 >方法:修改了两个先前发布的以QALY形式提供输出的模型来估计DALY:人乳头瘤病毒(HPV)疫苗接种的马尔可夫模型和肺炎球菌疫苗确定性模型(PNEUMO)。使用了阿根廷,智利和英国的研究,其中可以使用本地EQ-5D社会价值权重来提供本地QALY权重。进行了具有描述性渐晕的初步研究(n = 73),以获取两个模型中所有健康状态的EQ-5D数据。进行了几种情景分析,以评估使用不同指标(DALYS或QALYs)评估这些经济评估对健康的益处的相对重要性。 >结果:在所有国家/地区,HPV避免的DALY的QALY收益都更大,从而导致使用前者的决策更为有利。通过折现和年龄加权(在所有国家之间存在最大差异的情况),避免增加的DALY分别代表了阿根廷,智利和英国获得的QALY的75%,68%和43%。对于PNEUMO,使用QALY或DALY的差异不太一致,有时方向相反。与其他广泛使用的假设类似,这些差异可能会直接影响每个DALY或QALY阈值的人均通常国内生产总值(GDP)。 >结论:我们没有发现与许多研究人员和决策者当前使用QALY或DALY互换使用相矛盾的证据。度量选择的差异可能会影响最终决策,但与其他常用假设类似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号